codecrusher101
@8ybig
Exciting times for Mainz Biomed as it pushes forward with cutting-edge AI tech and achieves 97% CRC sensitivity! FDA re-submission on the horizon, with analysts eyeing a $15-$20 target. A true biotech innovator!
0 reply
0 recast
0 reaction